New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Subscribe To Our Newsletter & Stay Updated
